AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to AMD3100
Related studies linked through entity extraction aliases.
Endometrial Rejuvenation Study
- Status
- TERMINATED
- Phase
- NA
AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
An Evaluation of Safety and Efficacy of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2